CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raptis, L.
Right arrow Articles by Elliott, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raptis, L.
Right arrow Articles by Elliott, B. E.
Cell Growth & Differentiation Vol. 11, 293-303, June 2000
© 2000 American Association for Cancer Research

Specific Inhibition of Growth Factor-stimulated Extracellular Signal-regulated Kinase 1 and 2 Activation in Intact Cells by Electroporation of a Growth Factor Receptor-binding Protein 2-Src Homology 2 Binding Peptide1

Leda Raptis2, Heather L. Brownell3, Adina M. Vultur, Gregory M. Ross, Eric Tremblay and Bruce E. Elliott

Departments of Microbiology and Immunology [L. R., H. L. B., A. M. V., B. E. E.], Pathology [L. R., E. T., B. E. E.], and Medicine [G. M. R.], Queen’s University, Kingston, Ontario, K7L 3N6 Canada

Activation of the Ras pathway is central to mitogenesis by a variety of growth factors such as the epidermal growth factor, platelet-derived growth factor, or hepatocyte growth factor. Ras activation requires the function of adaptors such as growth factor receptor-binding protein 2, which can bind either directly or indirectly through Src homology 2 domains to the activated receptor. To examine the role of the Src homology 2 domain of growth factor receptor-binding protein 2 in the mitogenic response triggered by these growth factors, we introduced a peptide (PVPE-phosphono-methylphenylalanine-INQS) that can selectively bind this domain into mouse, rat, or human cells growing on conductive indium-tin oxide-coated glass by in situ electroporation. Cells were subsequently stimulated with growth factors and assessed for activation of a downstream target, extracellular signal-regulated kinase (ERK) 1/2, by probing with antibodies specific for its activated form. Electrodes and slides were configured to provide nonelectroporated control cells side by side with the electroporated ones, both growing on the same type of indium-tin oxide-coated glass surface. The data demonstrate that the peptide can cause a dramatic inhibition of epidermal growth factor or platelet-derived growth factor-mediated ERK1/2 activation and DNA synthesis in vivo, compared with its control phenylalanine-containing counterpart. In contrast, the peptide had a very limited effect on hepatocyte growth factor-triggered ERK1/2 activation and DNA synthesis. These results demonstrate the potential of the in situ electroporation approach described here in the study of the coupling of activated receptor tyrosine kinases to the ERK1/2 cascade.




This article has been cited by other articles:


Home page
Anticancer ResHome page
R. ARULANANDAM, M. GELETU, and L. RAPTIS
The Simian Virus 40 Large Tumor Antigen Activates cSrc and Requires cSrc for Full Neoplastic Transformation
Anticancer Res, January 1, 2010; 30(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Vultur, R. Arulanandam, J. Turkson, G. Niu, R. Jove, and L. Raptis
Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor Antigen
Mol. Biol. Cell, August 1, 2005; 16(8): 3832 - 3846.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Grammatikakis, K. Jaronczyk, A. Siganou, A. Vultur, H. L. Brownell, M. Benzaquen, C. Rausch, R. Lapointe, O. Gjoerup, T. M. Roberts, et al.
Simian Virus 40 Large Tumor Antigen Modulates the Raf Signaling Pathway
J. Biol. Chem., July 27, 2001; 276(30): 27840 - 27845.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Grammatikakis, K. Jaronczyk, A. Siganou, A. Vultur, H. L. Brownell, M. Benzaquen, C. Rausch, R. Lapointe, O. Gjoerup, T. M. Roberts, et al.
Simian Virus 40 Large Tumor Antigen Modulates the Raf Signaling Pathway
J. Biol. Chem., July 27, 2001; 276(30): 27840 - 27845.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2000 by the American Association of Cancer Research.